Spinocerebellar ataxia; Huntington's disease; and schizophrenia ...read more
My research focuses on the molecular pathogeneses of neurodegenerative disorders such as spinocerebellar ataxia types 2 and 12 (SCA2 and SCA12), and psychiatric disorders such as schizophrenia, with the goal of finding new therapeutic targets. Particular interest includes the molecular biology of disease loci containing expanded microsatellites, the contribution of antisense transcripts to pathogenesis, the role of RNA in neurotoxicity, exosome based drug delivery, and functional characterization of schizophrenia rare variants.
Pan P. Li, Xin Sun, Guangbin Xia, Nicolas Arbez, Sharan Paul, Shanshan Zhu, H. Benjamin Peng, Christopher A. Ross, Arnulf H. Koeppen, Russell L. Margolis, Stefan M. Pulst, Tetsuo Ashizawa, Dobrila D. Rudnicki (2016) ATXN2-AS, a gene antisense to ATXN2, is associated with SCA2 and ALS. Annals of Neurology 80 (4), 600-615
Pan P. Li*, Russell L. Margolis (2021) Use of single guided Cas9 nickase to facilitate precise and efficient genome editing in human iPSCs. Scientific Reports 11: 9865 doi: 10.1038/s41598-021-89312-2. PMID: 33972655 (* corresponding author)
Hongxuan Feng, Qinshan Li, Russell L. Margolis, Pan P. Li* (2021) Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing. Stem Cell Research 53: 102346 https://doi.org/10.1016/j.scr.2021.102346 (* corresponding author)
Pan P. Li*, Roumita Moulick, Hongxuan Feng, Xin Sun, Nicolas Arbez, Jing Jin, Leonard O. Marque, Erin Hedglen, H.Y. Edwin Chan, Christopher A. Ross, Stefan M. Pulst, Russell L. Margolis, Sarah Woodson, Dobrila D. Rudnicki (2021) RNA toxicity and perturbation of rRNA processing in spinocerebellar ataxia type 2. Movement Disorders 36 (11), 2519-2529 (* corresponding author)
Qian Li, Yi Feng, Yingchao Xue, Xiping Zhan, Yi Fu, Gege Gui, Weiqiang Zhou, Jean-Philippe Richard, Arens Taga, Pan P. Li, Xiaobo Mao, Nicholas J. Maragakis and Mingyao Ying (2022) Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells. Molecular Neurodegeneration 17(1):8 http://doi.org/10.1186/s13024-021-00510-y
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.